• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

LDC backs MBO of Enterprise Ventures-backed ChargePoint

  • Kenny Wastell
  • Kenny Wastell
  • @kennywastell
  • 10 January 2017
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

LDC has invested in the management buyout of Enterprise Ventures-backed ChargePoint Technology, a UK manufacturer of valves for use in the pharmaceutical, biotech and chemical sectors.

LDC has acquired a minority stake in the business as part of the deal, which was led by ChargePoint managing director Chris Eccles and sales director Tony O'Sullivan.

The transaction marks a full exit for Enterprise Ventures just three years after its original investment.

ChargePoint Technology

  • DEAL:

    SBO

  • LOCATION:

    Speke

  • SECTOR:

    Industrial machinery

  • FOUNDED:

    1996

  • TURNOVER:

    £8.1m

  • EBITDA:

    £2.3m

  • STAFF:

    60

  • VENDOR:

    Enterprise Ventures

Under its new ownership model, the company will look to undertake an international expansion strategy, with a particular focus on increasing sales in the North American market. The business will also look to make bolt-on acquisitions in order to expand into new, closely related sectors.

As part of the deal, former Penn Pharma CEO Richard Yarwood has also been appointed as non-executive chairperson of ChargePoint. Penn Pharma is a former LDC portfolio company that the GP sold to Packaging Coordinators for £127m, reaping almost 3x its original investment. LDC's Ged Gould and Chris Wright will also take seats on the ChargePoint board.

The transaction marks LDC's first investment of 2017 and the fourth investment in nine months made by its Manchester office. The Manchester team's previous deal  was the £20m investment in HR software company Mitrefinch.

The deal also marks the third exit by Enterprise Ventures Growth Fund in the space of three months, following the sale of its stake in tattoo and piercing business Barber of Sheffield to RJD Partners and its partial exit from Woodall Nicholson as part of a BGF funding round.

Debt
Crescent Capital Group provided debt facilities to support the transaction, a spokesperson for LDC told unquote".

Previous funding
Enterprise Ventures invested £1.6m in ChargePoint via its Coalfields Funds and North West Fund for Mezzanine in October 2013. The capital was structured as a mixture of debt and equity.

Company
Founded in 1996 and headquartered in Speke, near Liverpool, ChargePoint manufactures and distributes high-performance containment valves and sterile transfer valves for the pharmaceutical, biotech and chemical sectors. The business has a headcount of 60 and has additional operations across Europe, Asia and North America.

In the financial year ending December 2015, ChargePoint generated a turnover of £8.1m with EBITDA of £2.3m, according to publicly available records. According to a statement issued by LDC, the business reached its record EBITDA in 2016, while turnover during the year increased by 100% compared to the £5.6m generated in 2013.

People
LDC – Ged Gould (director); Chris Wright (investment director).
ChargePoint Technology – Chris Eccles (managing director).

Advisers
Equity – GCA Altium, Simon Lord, Adam Sivner (corporate finance); Addleshaw Goddard, Paul Medlicott, Katie Simpson (legal); Deloitte (financial due diligence); PMSI (commercial due diligence).
Company – Clearwater International, Paul Jones, Michael Loudon (corporate finance); Ward Hadaway, Sean Fitzgerald (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • UK / Ireland
  • Industrials
  • United Kingdom
  • Enterprise Ventures
  • LDC

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013